Sanofi B.V.
SpainAll drugs from this manufacturer
-
It is used to treat patients with MPS I (mucopolysaccharidosis I) disease, specifically to treat the non-neurological manifestations of this disease.
Dosage form: solution for infusion, concentrate
Active substance Dosage laronidase 100 U -
It is used for the treatment of chronic lymphocytic B-cell leukemia (CLL-B) in patients who have sufficient production of healthy blood cells and present with symptoms or disease progression.
Dosage form: tablets, film-coated
Active substance Dosage fludarabine phosphate 10 mg -
It is used to treat adults and children aged 5 years or older with a type of medullary thyroid cancer called RET (Rearranged during Transfection) mutant cancer that cannot be removed with surgery or that has spread to other parts of the body.
Dosage form: tablets, film-coated
Active substance Dosage vandetanib 100 mg -
It is used in adults and children aged 5 years or older to treat a type of medullary thyroid cancer called RET (Rearranged during Transfection) mutation cancer that cannot be removed by surgery or that has spread to other parts of the body.
Dosage form: tablets, film-coated
Active substance Dosage vandetanib 300 mg -
It is used for the long-term treatment of adults and children aged 6 years and older (weighing at least 15 kg) with type 1 Gaucher disease.
Dosage form: capsules, hard
Active substance Dosage eliglustat 84 mg -
It is used to treat patients with a confirmed diagnosis of type I or III Gaucher disease who present with symptoms such as anemia, tendency to bleed, enlargement of the spleen or liver, or bone problems.
Dosage form: solution for infusion, concentrate
Active substance Dosage imiglucerase 400 UI -
It is used as enzyme replacement therapy in patients with a confirmed diagnosis of Fabry disease, a condition in which there is insufficient activity of the α-galactosidase enzyme and a fatty substance accumulates in the walls of the blood vessels of the organs.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage agalsidase beta 5 mg -
It is used as enzyme replacement therapy to treat Fabry disease, a condition in which the body cannot properly eliminate a fatty substance called globotriaosylceramide (GL-3).
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage agalsidase beta 5 mg -
It is used to help collect stem cells from the blood of adult patients with lymphoma or multiple myeloma, and children aged 1 to less than 18 years with lymphoma or solid tumors, so that they can be stored and used in a transplant.
Dosage form: solution for injection
Active substance Dosage plerixafor 20 mg -
It is used for the treatment of adults, children, and adolescents with a confirmed diagnosis of Pompe disease. It helps replace an enzyme that is missing in the body to control glycogen levels.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage alglucosidase alfa 50 mg -
It is used to treat people of all ages suffering from Pompe disease, helping to reduce the accumulation of glycogen in the muscles.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage avalglucosidase alfa 10 mg/ml -
It is used to prevent and treat rejection in kidney transplants, for the treatment of severe aplastic anemia in certain patients, and to prevent rejection in hematopoietic progenitor cell transplantation.
Dosage form: powder for solution for infusion
Active substance Dosage rabbit antihuman thymocyte immunoglobulin 25 mg -
It is used to treat acid sphingomyelinase deficiency (ASMD), a hereditary disorder, in children and adults with types A/B or B. It helps treat the signs and symptoms of this disease that are not related to the brain.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage olipudase alfa 20 mg -
It is used to treat acid sphingomyelinase deficiency (ASMD), a hereditary disorder, in children and adults with types A/B or B. It helps treat the signs and symptoms of this disease that are not related to the brain.
Dosage form: powder for concentrate for solution for infusion
Active substance Dosage olipudase alfa 4 mg